Vor Biopharma Inc. · NASDAQ:VOR
Verve Capital Limited reported a 9.90% stake in Vor Biopharma Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Verve Capital Limited reported a 9.90% stake in Vor Biopharma Inc., 4,297,464 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 4,297,464
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Verve Capital Limited | 9.90% | 4,297,464 |
Source
Related
- Vor Biopharma Inc.
- Verve Capital Limited
- Vor Biopharma Inc. shareholders
- Schedule 13G/A · Verve Capital Limited · Aug 13, 2026
- Schedule 13G/A · Verve Capital Limited · May 15, 2026
- Schedule 13G · Verve Capital Limited · Sep 26, 2025
- Form 4 · Ra Capital Management, L.P. · Oct 5, 2026
- Form 4 · RA Capital Healthcare Fund LP · Aug 26, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Aug 14, 2026
- Schedule 13G/A · FMR LLC · Aug 7, 2026